|
SPATA5L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.135600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.143200E-01 |
| Normal-vs-Stage2 |
7.708000E-01 |
| Normal-vs-Stage3 |
1.279790E-01 |
| Normal-vs-Stage4 |
7.520000E-01 |
| Stage1-vs-Stage2 |
9.294600E-01 |
| Stage1-vs-Stage3 |
7.039900E-02 |
| Stage1-vs-Stage4 |
5.534200E-01 |
| Stage2-vs-Stage3 |
1.815650E-01 |
| Stage2-vs-Stage4 |
6.584400E-01 |
| Stage3-vs-Stage4 |
4.960000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.973200E-01 |
| Normal-vs-AfricanAmerican |
9.319600E-01 |
| Normal-vs-Asian |
2.456800E-01 |
| Caucasian-vs-AfricanAmerican |
9.305000E-01 |
| Caucasian-vs-Asian |
2.460000E-01 |
| AfricanAmerican-vs-Asian |
6.464400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.240200E-01 |
| Normal-vs-Female |
2.465500E-02 |
| Male-vs-Female |
3.135700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.992000E-01 |
| Normal-vs-Extreme_Weight |
8.842000E-02 |
| Normal-vs-Obese |
5.771400E-01 |
| Normal-vs-Extreme_Obese |
8.909000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.118400E-01 |
| Normal_Weight-vs-Obese |
8.499200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.980600E-01 |
| Extreme_Weight-vs-Obese |
9.720200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.900000E-01 |
| Obese-vs-Extreme_Obese |
9.126600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.115600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.167600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.491200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.409000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.754100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.763500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.928000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.725000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.664400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.228600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.608400E-01 |
| Normal-VS-Type2 PRCC |
8.415000E-01 |
| Normal-VS-KIRP CIMP |
6.504500E-02 |
| Normal-VS-Unclassified PRCC |
3.461400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.650800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.203400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.586600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.178000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.013200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.262360E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.808200E-01 |
| Normal-vs-N1 |
1.235190E-01 |
| Normal-vs-N2 |
5.671600E-01 |
| N0-vs-N1 |
9.223800E-02 |
| N0-vs-N2 |
5.988200E-01 |
| N1-vs-N2 |
2.806800E-01 |
|
|
